C. Moriano

518 total citations
18 papers, 59 citations indexed

About

C. Moriano is a scholar working on Rheumatology, Immunology and Ophthalmology. According to data from OpenAlex, C. Moriano has authored 18 papers receiving a total of 59 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 6 papers in Immunology and 4 papers in Ophthalmology. Recurrent topics in C. Moriano's work include Systemic Lupus Erythematosus Research (11 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and T-cell and B-cell Immunology (3 papers). C. Moriano is often cited by papers focused on Systemic Lupus Erythematosus Research (11 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and T-cell and B-cell Immunology (3 papers). C. Moriano collaborates with scholars based in Spain, United States and Italy. C. Moriano's co-authors include Ricardo Blanco, Miguel Á. González‐Gay, Belén Atienza‐Mateo, José A. Miranda‐Filloy, José L. Hernández, Ignacio Villa, Joan M. Nolla, A. Atanes, Sara Remuzgo‐Martínez and Marcelino Revenga and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Seminars in Arthritis and Rheumatism.

In The Last Decade

C. Moriano

11 papers receiving 59 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Moriano Spain 5 39 35 21 13 6 18 59
Alice Bartoletti Italy 3 29 0.7× 40 1.1× 8 0.4× 11 0.8× 3 0.5× 8 52
E. Galíndez-Agirregoikoa Spain 4 25 0.6× 15 0.4× 6 0.3× 7 0.5× 4 0.7× 7 35
Janice Lin United States 3 32 0.8× 30 0.9× 3 0.1× 4 0.3× 4 58
Ludovic Tréfond France 4 19 0.5× 7 0.2× 7 0.3× 7 0.5× 2 0.3× 9 57
Amy Stockwell United States 4 11 0.3× 49 1.4× 4 0.2× 6 0.5× 9 1.5× 4 74
C. Fernández-Díaz Spain 4 27 0.7× 23 0.7× 25 1.2× 1 0.1× 2 0.3× 8 56
Karl Bleasel Australia 4 12 0.3× 31 0.9× 3 0.1× 12 0.9× 2 0.3× 4 44
J. Desblache France 3 30 0.8× 5 0.1× 9 0.4× 2 0.2× 3 0.5× 6 66
Sapan C Pandya India 4 50 1.3× 20 0.6× 10 0.8× 5 0.8× 20 67
E. Van Essche Belgium 2 15 0.4× 42 1.2× 3 0.1× 4 0.3× 2 87

Countries citing papers authored by C. Moriano

Since Specialization
Citations

This map shows the geographic impact of C. Moriano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Moriano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Moriano more than expected).

Fields of papers citing papers by C. Moriano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Moriano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Moriano. The network helps show where C. Moriano may publish in the future.

Co-authorship network of co-authors of C. Moriano

This figure shows the co-authorship network connecting the top 25 collaborators of C. Moriano. A scholar is included among the top collaborators of C. Moriano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Moriano. C. Moriano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
3.
Santos, C. Sieiro, et al.. (2023). AB0862 NAILFOLD CAPILLAROSCOPY FOR PREDICTION OF NOVEL SEVERE ORGAN INVOLVEMENT IN SYSTEMIC SCLEROSIS. Annals of the Rheumatic Diseases. 82. 1644–1644. 1 indexed citations
4.
Moriano, C., et al.. (2023). AB0698 SYSTEMIC LUPUS ERYTHEMATOSUS OVER 80 YEARS OF AGE: A RETROSPECTIVE COHORT OF VERY LATE-ONSET IN A THIRD LEVEL HOSPITAL. Annals of the Rheumatic Diseases. 82. 1552–1553. 1 indexed citations
5.
Moriano, C., et al.. (2023). Evolution of diagnosis and treatment for lupus nephritis in Spain. Nefrología (English Edition). 43(6). 668–675. 1 indexed citations
6.
Santos, C. Sieiro, et al.. (2022). AB0451 FACTORS ASSOCIATED WITH ADVERSE PREGNANCY OUTCOMES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE). Annals of the Rheumatic Diseases. 81. 1353–1353. 1 indexed citations
7.
Moriano, C., et al.. (2022). Evolución del diagnóstico y tratamiento de la nefritis lúpica en España. SHILAP Revista de lepidopterología. 43(6). 668–675.
8.
9.
Calderón-Goercke, Monica, Santos Castañeda, Ignacio Villa, et al.. (2021). Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients. Seminars in Arthritis and Rheumatism. 51(2). 387–394. 17 indexed citations
10.
Atienza‐Mateo, Belén, E. Beltrán, Marisa Hernández‐Garfella, et al.. (2021). Tocilizumab in Behçet's disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes.. PubMed. 39 Suppl 132(5). 37–42. 8 indexed citations
11.
Atienza‐Mateo, Belén, E. Beltrán, Marisa Hernández‐Garfella, et al.. (2021). Tocilizumab in Behçet's disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes. Clinical and Experimental Rheumatology. 39(5). 37–42. 14 indexed citations
12.
Prieto-Peña, D., Sara Remuzgo‐Martínez, J. Gonzalo Ocejo‐Vinyals, et al.. (2020). Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association. Seminars in Arthritis and Rheumatism. 50(5). 897–901. 9 indexed citations
13.
Moriano, C., et al.. (2020). SAT0180 ANTIMALARIAL DRUGS ASSOCIATED RETINOPATHY IN SYSTEMIC LUPUS ERYTHEMATOSUS. Annals of the Rheumatic Diseases. 79. 1031–1031.
14.
Martín-Varillas, J. L., Belén Atienza‐Mateo, J. Loricera, et al.. (2019). FRI0202 SHORT AND LONG-TERM FOLLOW-UP OF APREMILAST THERAPY IN REFRACTORY SKIN LUPUS LESIONS. Annals of the Rheumatic Diseases. 78. 780–780.
15.
Moriano, C., et al.. (2018). AB0507 Belimumab in patients with systemic lupus erythematosus: outcomes in routine clinical practice. Annals of the Rheumatic Diseases. 77. 1413–1413. 4 indexed citations
16.
Moriano, C., et al.. (2018). AB0550 Clinical-epidemiological features of patients with a late-onset lupus in a tertiary care hospital. Annals of the Rheumatic Diseases. 77. 1431–1431. 1 indexed citations
17.
Moriano, C., et al.. (2018). AB1236 Therapeutic adherence and satisfaction in a rheumatology consultation. Annals of the Rheumatic Diseases. 77. 1715–1715.
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alice Bartoletti Breakdown of academic impact, for papers by E. Galíndez-Agirregoikoa Breakdown of academic impact, for papers by Janice Lin Breakdown of academic impact, for papers by Ludovic Tréfond Breakdown of academic impact, for papers by Amy Stockwell Breakdown of academic impact, for papers by C. Fernández-Díaz Breakdown of academic impact, for papers by Karl Bleasel Breakdown of academic impact, for papers by J. Desblache Breakdown of academic impact, for papers by Sapan C Pandya Breakdown of academic impact, for papers by E. Van Essche
Rankless by CCL
2026